866-997-4948(US-Canada Toll Free)

Hemophilia A Global Clinical Trials Review, H2, 2017

Published By :

GlobalData

Published Date : Sep 2017

Category :

Pharmaceutical

No. of Pages : 235 Pages

Hemophilia A Global Clinical Trials Review, H2, 2017

Summary

GlobalData's clinical trial report, Hemophilia A Global Clinical Trials Review, H2, 2017" provides an overview of Hemophilia A clinical trials scenario. This report provides top line data relating to the clinical trials on Hemophilia A. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Hemophilia A to Hematological Disorders Clinical Trials 17
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Hemophilia A to Hematological Disorders Clinical Trials 20
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 26
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Hemophilia A Therapeutics Clinical Trials 30
Prominent Drugs 31
Latest Clinical Trials News on Hemophilia A 32
Sep 07, 2017: Sanofi Alliance Partner Alnylam Provides Update on Fitusiran Development Program 32
Aug 23, 2017: Publication of clinical data demonstrating low immunogenicity and excellent efficacy of Nuwiq in previously untreated patients 32
Jul 10, 2017: Positive phase III results for Roches emicizumab in haemophilia A published in The New England Journal of Medicine 32
Jul 10, 2017: Sanofi Genzyme and Alnylam Report Positive Results from Ongoing Phase 2 Open-Label Extension Study with Investigational RNAi Therapeutic Fitusiran in Patients with Hemophilia A and B With or Without Inhibitors 34
Jul 10, 2017: New Findings Show AFSTYLA Provides Long-lasting Efficacy without Increased Product Consumption for Prophylactic and On-Demand Treatment of Haemophilia A 34
Jul 10, 2017: ISTH 2017, Berlin: Octapharma presents exciting Nuwiq data in previously untreated patients and demonstrates real-life value of personalised prophylaxis for Haemophilia A 35
Jul 07, 2017: Alnylam and Sanofi Genzyme Initiate ATLAS Phase 3 Program with Investigational RNAi Therapeutic Fitusiran in Patients with Hemophilia A and B with or without Inhibitors 36
Jul 06, 2017: New Data for Leading Haemophilia Medicine AFSTYLA to be Presented at the International Society on Thrombosis and Haemostasis Congress 2017 36
Jul 06, 2017: Sobi and Bioverativ Announces Data on Alprolix at ISTH 2017 Congress 37
Jul 06, 2017: Sobi and Bioverativ Announces Data on Elocta at ISTH 2017 Congress 37
Jul 03, 2017: Bayer Announces Data on Kovaltry (octocog alfa) at ISTH 2017 38
Jul 03, 2017: Bayer To Present New Data on Kogenate Bayer at ISTH 2017 39
Jun 26, 2017: Alnylam and Sanofi Genzyme to Present New Clinical Trial Results at the International Society of Thrombosis and Haemostasis (ISTH) Congress 39
Jun 23, 2017: Shire to present new data on SHP654 at ISTH 2017 to advance the standard of care in Hemophilia 39
Clinical Trial Profile Snapshots 41
Appendix 233
Abbreviations 233
Definitions 233
Research Methodology 234
Secondary Research 234
About GlobalData 235
Contact Us 235
Source 235

List of Tables
Hemophilia A Therapeutics, Global, Clinical Trials by Region, 2017* 8
Hemophilia A Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 10
Hemophilia A Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
Hemophilia A Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 12
Hemophilia A Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 13
Hemophilia A Therapeutics Clinical Trials, North America, Top Countries, 2017* 14
Hemophilia A Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 15
Hemophilia A Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 16
Proportion of Hemophilia A to Hematological Disorders Clinical Trials, G7 Countries (%), 2017* 17
Hemophilia A Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
Hemophilia A Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
Proportion of Hemophilia A to Hematological Disorders Clinical Trials, E7 Countries (%), 2017* 20
Hemophilia A Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21
Hemophilia A Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 22
Hemophilia A Therapeutics, Global, Clinical Trials by Phase, 2017* 23
Hemophilia A Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 24
Hemophilia A Therapeutics, Global, Clinical Trials by Trial Status, 2017* 25
Hemophilia A Therapeutics Clinical Trials, Global, by End Point Status, 2017* 26
Hemophilia A Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 27
Hemophilia A Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 28
Hemophilia A Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
Hemophilia A Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
Hemophilia A Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 31

List of Figures
Hemophilia A Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
Hemophilia A Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Hemophilia A Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
Hemophilia A Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 12
Hemophilia A Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 13
Hemophilia A Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 14
Hemophilia A Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 15
Hemophilia A Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 16
Proportion of Hemophilia A to Hematological Disorders Clinical Trials, G7 Countries (%), 2017* 17
Hemophilia A Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
Hemophilia A Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
Proportion of Hemophilia A to Hematological Disorders Clinical Trials, E7 Countries (%), 2017* 20
Hemophilia A Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21
Hemophilia A Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 22
Hemophilia A Therapeutics, Global, Clinical Trials by Phase (%), 2017* 23
Hemophilia A Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 24
Hemophilia A Therapeutics, Global, Clinical Trials by Trial Status, 2017* 25
Hemophilia A Therapeutics Clinical Trials, Global, by End Point Status, 2017* 26
Hemophilia A Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 27
Hemophilia A Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 28
Hemophilia A Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
Hemophilia A Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
Hemophilia A Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 31
GlobalData Methodology 234

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *